Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skin | 24 | 2024 | 4489 | 2.630 |
Why?
|
Skin Diseases | 12 | 2023 | 1088 | 2.250 |
Why?
|
Calciphylaxis | 10 | 2023 | 130 | 2.090 |
Why?
|
Exanthema | 7 | 2023 | 502 | 1.770 |
Why?
|
Keratin-17 | 4 | 2022 | 26 | 1.610 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 8 | 2016 | 42 | 1.590 |
Why?
|
Sweat Gland Neoplasms | 5 | 2024 | 110 | 1.510 |
Why?
|
Churg-Strauss Syndrome | 2 | 2022 | 74 | 1.470 |
Why?
|
Skin Neoplasms | 22 | 2024 | 5849 | 1.440 |
Why?
|
Encephalocele | 2 | 2023 | 135 | 1.420 |
Why?
|
Drug Eruptions | 4 | 2023 | 335 | 1.230 |
Why?
|
Carcinoma, Basal Cell | 3 | 2022 | 566 | 1.180 |
Why?
|
Psoriasis | 4 | 2023 | 919 | 1.170 |
Why?
|
Dermis | 3 | 2021 | 204 | 1.110 |
Why?
|
Scleritis | 2 | 2020 | 96 | 1.010 |
Why?
|
Scleroderma, Diffuse | 2 | 2015 | 18 | 0.980 |
Why?
|
Eosinophilia | 2 | 2022 | 556 | 0.970 |
Why?
|
Eczema | 2 | 2023 | 246 | 0.830 |
Why?
|
Keloid | 2 | 2020 | 55 | 0.810 |
Why?
|
Melanocytes | 4 | 2018 | 515 | 0.800 |
Why?
|
Carcinoma, Squamous Cell | 7 | 2024 | 4044 | 0.800 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2020 | 80 | 0.780 |
Why?
|
Nevus | 1 | 2024 | 205 | 0.780 |
Why?
|
Acantholysis | 1 | 2021 | 11 | 0.760 |
Why?
|
Th17 Cells | 3 | 2017 | 786 | 0.750 |
Why?
|
Diagnosis, Differential | 20 | 2022 | 12976 | 0.750 |
Why?
|
Meninges | 1 | 2023 | 200 | 0.730 |
Why?
|
Anus Neoplasms | 2 | 2016 | 336 | 0.730 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2017 | 975 | 0.720 |
Why?
|
Colostomy | 1 | 2021 | 107 | 0.720 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 159 | 0.700 |
Why?
|
Pemphigus | 1 | 2021 | 107 | 0.690 |
Why?
|
Vasculitis | 2 | 2017 | 527 | 0.680 |
Why?
|
Herpesvirus 2, Human | 1 | 2021 | 191 | 0.680 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2019 | 19 | 0.670 |
Why?
|
Tinea Capitis | 1 | 2019 | 16 | 0.670 |
Why?
|
Scalp | 3 | 2021 | 388 | 0.650 |
Why?
|
Antibodies, Antinuclear | 2 | 2020 | 340 | 0.640 |
Why?
|
Hair Follicle | 1 | 2021 | 224 | 0.630 |
Why?
|
Sarcoma, Kaposi | 3 | 2017 | 375 | 0.620 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2020 | 80 | 0.620 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2017 | 4348 | 0.600 |
Why?
|
Pathology | 1 | 2021 | 270 | 0.600 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2019 | 164 | 0.600 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2020 | 283 | 0.600 |
Why?
|
Herpes Simplex | 1 | 2021 | 472 | 0.590 |
Why?
|
Alopecia | 2 | 2021 | 414 | 0.570 |
Why?
|
Antigens, Differentiation | 2 | 2017 | 919 | 0.550 |
Why?
|
Cicatrix | 2 | 2020 | 798 | 0.550 |
Why?
|
Urticaria | 2 | 2016 | 151 | 0.550 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2017 | 178 | 0.540 |
Why?
|
Kidney Failure, Chronic | 6 | 2019 | 2495 | 0.530 |
Why?
|
Scleroderma, Localized | 1 | 2017 | 85 | 0.530 |
Why?
|
Fasciitis | 1 | 2017 | 68 | 0.520 |
Why?
|
Dermatitis, Atopic | 2 | 2015 | 729 | 0.520 |
Why?
|
Immunohistochemistry | 16 | 2022 | 11022 | 0.510 |
Why?
|
Stromal Cells | 1 | 2021 | 1329 | 0.510 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-kit | 3 | 2017 | 723 | 0.500 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2016 | 143 | 0.500 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 385 | 0.500 |
Why?
|
Dermatitis | 1 | 2017 | 199 | 0.500 |
Why?
|
Dermatitis, Exfoliative | 1 | 2015 | 28 | 0.500 |
Why?
|
Temporal Arteries | 1 | 2017 | 154 | 0.500 |
Why?
|
Neoplasms, Basal Cell | 1 | 2015 | 30 | 0.490 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 587 | 0.490 |
Why?
|
Telepathology | 2 | 2014 | 77 | 0.490 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 166 | 0.490 |
Why?
|
Biopsy | 17 | 2021 | 6763 | 0.480 |
Why?
|
Cultural Diversity | 1 | 2019 | 370 | 0.480 |
Why?
|
Th1 Cells | 2 | 2017 | 1039 | 0.480 |
Why?
|
Congresses as Topic | 1 | 2019 | 811 | 0.460 |
Why?
|
Wound Healing | 4 | 2020 | 2792 | 0.460 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1240 | 0.450 |
Why?
|
Carcinoma, Basosquamous | 1 | 2013 | 7 | 0.450 |
Why?
|
Keratin-14 | 1 | 2013 | 57 | 0.440 |
Why?
|
Melanoma | 10 | 2018 | 5719 | 0.440 |
Why?
|
Th2 Cells | 2 | 2016 | 1075 | 0.430 |
Why?
|
Physicians, Women | 1 | 2019 | 512 | 0.430 |
Why?
|
Immunoglobulin G | 3 | 2018 | 4528 | 0.430 |
Why?
|
Sarcoma, Myeloid | 1 | 2013 | 52 | 0.420 |
Why?
|
Dermatology | 2 | 2021 | 907 | 0.420 |
Why?
|
Remote Consultation | 2 | 2014 | 240 | 0.420 |
Why?
|
Humans | 105 | 2024 | 765968 | 0.410 |
Why?
|
Adenocarcinoma | 2 | 2024 | 6364 | 0.410 |
Why?
|
Scleroderma, Systemic | 3 | 2023 | 346 | 0.410 |
Why?
|
Gadolinium | 4 | 2013 | 965 | 0.410 |
Why?
|
Granuloma Annulare | 1 | 2013 | 31 | 0.400 |
Why?
|
Thyroid Diseases | 1 | 2016 | 388 | 0.400 |
Why?
|
Sweet Syndrome | 1 | 2013 | 59 | 0.400 |
Why?
|
Hedgehog Proteins | 1 | 2016 | 774 | 0.390 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2012 | 47 | 0.390 |
Why?
|
Male | 65 | 2024 | 363698 | 0.380 |
Why?
|
Autoimmune Diseases | 2 | 2016 | 2226 | 0.380 |
Why?
|
Minority Groups | 1 | 2019 | 1207 | 0.370 |
Why?
|
Caveolin 1 | 1 | 2013 | 255 | 0.370 |
Why?
|
Onychomycosis | 1 | 2011 | 50 | 0.360 |
Why?
|
Aged | 41 | 2024 | 171117 | 0.360 |
Why?
|
Substance Abuse, Intravenous | 1 | 2015 | 531 | 0.360 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2017 | 2056 | 0.350 |
Why?
|
Herpes Zoster | 1 | 2013 | 252 | 0.340 |
Why?
|
Middle Aged | 45 | 2024 | 223009 | 0.330 |
Why?
|
Piperazines | 1 | 2020 | 2549 | 0.320 |
Why?
|
Adenoma, Sweat Gland | 1 | 2009 | 18 | 0.320 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 637 | 0.320 |
Why?
|
Female | 61 | 2024 | 396112 | 0.320 |
Why?
|
Complement System Proteins | 1 | 2011 | 715 | 0.300 |
Why?
|
Carcinoma in Situ | 1 | 2014 | 779 | 0.300 |
Why?
|
Pyridines | 1 | 2020 | 2888 | 0.290 |
Why?
|
Societies, Medical | 1 | 2019 | 3956 | 0.280 |
Why?
|
Adult | 33 | 2023 | 223044 | 0.280 |
Why?
|
Retrospective Studies | 19 | 2023 | 81514 | 0.270 |
Why?
|
Specimen Handling | 1 | 2011 | 704 | 0.270 |
Why?
|
Neoplasm Proteins | 2 | 2016 | 3596 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3513 | 0.260 |
Why?
|
Aged, 80 and over | 17 | 2021 | 59489 | 0.250 |
Why?
|
Pathology, Clinical | 4 | 2014 | 377 | 0.250 |
Why?
|
Calcium | 1 | 2018 | 5767 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 5 | 2023 | 2310 | 0.240 |
Why?
|
Warfarin | 2 | 2014 | 1494 | 0.240 |
Why?
|
Bony Callus | 1 | 2024 | 41 | 0.240 |
Why?
|
Kidney Diseases | 2 | 2015 | 2098 | 0.230 |
Why?
|
Arthralgia | 2 | 2020 | 459 | 0.220 |
Why?
|
Hyperpigmentation | 2 | 2015 | 117 | 0.210 |
Why?
|
Fatal Outcome | 5 | 2015 | 1831 | 0.210 |
Why?
|
Asthma | 1 | 2022 | 6270 | 0.210 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1404 | 0.200 |
Why?
|
Burns | 3 | 2020 | 1903 | 0.200 |
Why?
|
Purpura | 2 | 2015 | 115 | 0.200 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13648 | 0.200 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1808 | 0.200 |
Why?
|
Relaxin | 1 | 2022 | 42 | 0.200 |
Why?
|
Receptors, Calcitriol | 2 | 2016 | 361 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2942 | 0.190 |
Why?
|
Pathology, Surgical | 2 | 2014 | 147 | 0.190 |
Why?
|
Intertrigo | 1 | 2021 | 2 | 0.190 |
Why?
|
Fracture Healing | 1 | 2024 | 448 | 0.190 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2021 | 67 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8611 | 0.190 |
Why?
|
Myxoma | 1 | 2022 | 115 | 0.180 |
Why?
|
Signal Transduction | 5 | 2019 | 23601 | 0.180 |
Why?
|
Leg | 2 | 2020 | 1080 | 0.180 |
Why?
|
Lichen Planus | 1 | 2021 | 71 | 0.170 |
Why?
|
Papillomavirus Infections | 2 | 2024 | 1640 | 0.170 |
Why?
|
Internship and Residency | 2 | 2019 | 5946 | 0.170 |
Why?
|
Phenotype | 4 | 2023 | 16721 | 0.170 |
Why?
|
Ribosomal Protein S6 | 2 | 2017 | 70 | 0.170 |
Why?
|
Eccrine Glands | 1 | 2020 | 51 | 0.170 |
Why?
|
Ichthyosis | 1 | 2019 | 58 | 0.160 |
Why?
|
Blood Sedimentation | 1 | 2020 | 233 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2020 | 173 | 0.160 |
Why?
|
STAT Transcription Factors | 1 | 2019 | 189 | 0.160 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9249 | 0.160 |
Why?
|
Hematuria | 1 | 2020 | 230 | 0.150 |
Why?
|
Fibrosis | 4 | 2023 | 2070 | 0.150 |
Why?
|
Poroma | 1 | 2018 | 8 | 0.150 |
Why?
|
Skin Ulcer | 2 | 2024 | 130 | 0.150 |
Why?
|
Edema | 2 | 2015 | 760 | 0.150 |
Why?
|
Janus Kinases | 1 | 2019 | 253 | 0.150 |
Why?
|
Carcinoma | 2 | 2020 | 2312 | 0.150 |
Why?
|
Heart Neoplasms | 1 | 2022 | 375 | 0.150 |
Why?
|
Lentigo | 1 | 2018 | 37 | 0.150 |
Why?
|
Arthritis | 2 | 2016 | 677 | 0.150 |
Why?
|
Contrast Media | 7 | 2015 | 5329 | 0.150 |
Why?
|
Treponema pallidum | 1 | 2018 | 48 | 0.150 |
Why?
|
Papillomaviridae | 2 | 2024 | 1141 | 0.140 |
Why?
|
Nail Diseases | 1 | 2018 | 54 | 0.140 |
Why?
|
Herpesvirus 8, Human | 2 | 2017 | 254 | 0.140 |
Why?
|
False Negative Reactions | 1 | 2018 | 573 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 836 | 0.140 |
Why?
|
Neovascularization, Physiologic | 1 | 2024 | 1375 | 0.140 |
Why?
|
Telangiectasis | 1 | 2017 | 77 | 0.140 |
Why?
|
Neurothekeoma | 1 | 2016 | 4 | 0.140 |
Why?
|
Symbiosis | 1 | 2019 | 297 | 0.140 |
Why?
|
Hypergammaglobulinemia | 1 | 2017 | 70 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3646 | 0.140 |
Why?
|
Thrombophilia | 1 | 2020 | 308 | 0.140 |
Why?
|
Deoxyribonucleases | 1 | 2018 | 209 | 0.140 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 598 | 0.130 |
Why?
|
Carboxylic Acids | 1 | 2017 | 91 | 0.130 |
Why?
|
Thumb | 1 | 2018 | 233 | 0.130 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6942 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 3 | 2024 | 8102 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2016 | 2054 | 0.130 |
Why?
|
Salivary Glands | 1 | 2017 | 231 | 0.130 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2017 | 67 | 0.130 |
Why?
|
Sweating | 1 | 2017 | 155 | 0.130 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1761 | 0.130 |
Why?
|
Nod2 Signaling Adaptor Protein | 1 | 2016 | 85 | 0.130 |
Why?
|
Sjogren's Syndrome | 1 | 2017 | 239 | 0.120 |
Why?
|
Phosphorylation | 5 | 2019 | 8278 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2020 | 16047 | 0.120 |
Why?
|
Uremia | 2 | 2015 | 202 | 0.120 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1461 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2020 | 878 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 545 | 0.120 |
Why?
|
Scleromyxedema | 1 | 2015 | 8 | 0.120 |
Why?
|
Anticoagulants | 2 | 2020 | 4862 | 0.120 |
Why?
|
Mouth | 1 | 2018 | 381 | 0.120 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.120 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2016 | 170 | 0.120 |
Why?
|
Colitis, Ischemic | 1 | 2015 | 32 | 0.120 |
Why?
|
Triamcinolone Acetonide | 1 | 2015 | 105 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2020 | 752 | 0.120 |
Why?
|
Mycobacterium chelonae | 1 | 2014 | 12 | 0.120 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3602 | 0.120 |
Why?
|
Hypersensitivity, Delayed | 1 | 2015 | 490 | 0.120 |
Why?
|
DNA, Viral | 1 | 2021 | 2199 | 0.120 |
Why?
|
Lumbar Vertebrae | 1 | 2024 | 1873 | 0.120 |
Why?
|
Necrosis | 3 | 2019 | 1617 | 0.120 |
Why?
|
Heroin Dependence | 1 | 2015 | 175 | 0.120 |
Why?
|
GATA3 Transcription Factor | 1 | 2015 | 163 | 0.120 |
Why?
|
Leg Injuries | 1 | 2016 | 179 | 0.120 |
Why?
|
Spinal Fusion | 1 | 2024 | 1302 | 0.120 |
Why?
|
Chronic Disease | 3 | 2019 | 9347 | 0.110 |
Why?
|
Eye Diseases | 1 | 2020 | 659 | 0.110 |
Why?
|
Autopsy | 2 | 2009 | 1011 | 0.110 |
Why?
|
Splenic Neoplasms | 1 | 2015 | 97 | 0.110 |
Why?
|
Colchicine | 1 | 2016 | 256 | 0.110 |
Why?
|
Synovitis | 1 | 2016 | 209 | 0.110 |
Why?
|
Young Adult | 10 | 2021 | 59889 | 0.110 |
Why?
|
Vitamin K | 1 | 2017 | 312 | 0.110 |
Why?
|
Lasers | 1 | 2018 | 951 | 0.110 |
Why?
|
Gout Suppressants | 1 | 2016 | 176 | 0.110 |
Why?
|
Calcitriol | 1 | 2015 | 299 | 0.110 |
Why?
|
Mastocytosis | 1 | 2016 | 151 | 0.110 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2014 | 86 | 0.110 |
Why?
|
Pharyngitis | 1 | 2015 | 221 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1562 | 0.110 |
Why?
|
Materials Testing | 1 | 2017 | 868 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3336 | 0.110 |
Why?
|
Spinal Neoplasms | 1 | 2020 | 708 | 0.110 |
Why?
|
Skin Pigmentation | 1 | 2015 | 279 | 0.110 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2016 | 456 | 0.110 |
Why?
|
Digestive System Neoplasms | 1 | 2013 | 82 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Ioxaglic Acid | 1 | 2012 | 29 | 0.100 |
Why?
|
Adjuvants, Immunologic | 1 | 2018 | 995 | 0.100 |
Why?
|
Lymphocyte Count | 1 | 2015 | 790 | 0.100 |
Why?
|
Pruritus | 1 | 2016 | 378 | 0.100 |
Why?
|
Panniculitis | 1 | 2013 | 46 | 0.100 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2921 | 0.100 |
Why?
|
Skin Diseases, Vascular | 1 | 2013 | 42 | 0.100 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 469 | 0.100 |
Why?
|
Metaplasia | 1 | 2013 | 326 | 0.100 |
Why?
|
Biopsy, Needle | 3 | 2017 | 1628 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2020 | 1083 | 0.100 |
Why?
|
Histiocytes | 1 | 2013 | 95 | 0.100 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2017 | 728 | 0.100 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 833 | 0.100 |
Why?
|
Mutation | 5 | 2024 | 30198 | 0.100 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15398 | 0.100 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2010 | 202 | 0.100 |
Why?
|
Giant Cells | 1 | 2013 | 187 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 412 | 0.100 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 844 | 0.100 |
Why?
|
Molluscum Contagiosum | 1 | 2012 | 15 | 0.100 |
Why?
|
Africa, Eastern | 1 | 2012 | 76 | 0.100 |
Why?
|
Pancytopenia | 1 | 2013 | 101 | 0.100 |
Why?
|
STAT3 Transcription Factor | 2 | 2015 | 870 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2017 | 1077 | 0.100 |
Why?
|
Uveitis | 1 | 2016 | 398 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 834 | 0.100 |
Why?
|
Rats | 8 | 2024 | 23707 | 0.100 |
Why?
|
Sodium Hydroxide | 1 | 2011 | 37 | 0.100 |
Why?
|
beta Catenin | 1 | 2016 | 1043 | 0.090 |
Why?
|
Drug Resistance | 1 | 2017 | 1591 | 0.090 |
Why?
|
Nevus, Blue | 1 | 2011 | 45 | 0.090 |
Why?
|
Adolescent | 8 | 2021 | 88835 | 0.090 |
Why?
|
Interleukin-17 | 1 | 2017 | 921 | 0.090 |
Why?
|
Codon | 1 | 2013 | 595 | 0.090 |
Why?
|
Docosahexaenoic Acids | 1 | 2018 | 916 | 0.090 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2010 | 266 | 0.090 |
Why?
|
Computer Simulation | 1 | 2024 | 6255 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2015 | 617 | 0.090 |
Why?
|
Gene Frequency | 2 | 2020 | 3624 | 0.090 |
Why?
|
CD4 Lymphocyte Count | 1 | 2017 | 2587 | 0.090 |
Why?
|
Mutation, Missense | 1 | 2020 | 2589 | 0.090 |
Why?
|
Databases, Factual | 2 | 2018 | 8067 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 634 | 0.090 |
Why?
|
Ki-67 Antigen | 2 | 2011 | 629 | 0.090 |
Why?
|
Microscopy | 2 | 2014 | 901 | 0.090 |
Why?
|
Tissue Scaffolds | 1 | 2017 | 934 | 0.090 |
Why?
|
Introns | 1 | 2013 | 966 | 0.090 |
Why?
|
MART-1 Antigen | 1 | 2010 | 65 | 0.090 |
Why?
|
Melanoma-Specific Antigens | 1 | 2010 | 75 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 497 | 0.080 |
Why?
|
Oncogenes | 2 | 2019 | 1235 | 0.080 |
Why?
|
Vaccines | 1 | 2018 | 841 | 0.080 |
Why?
|
Nevus, Pigmented | 1 | 2012 | 227 | 0.080 |
Why?
|
Immunocompromised Host | 3 | 2024 | 866 | 0.080 |
Why?
|
Glycosaminoglycans | 1 | 2012 | 606 | 0.080 |
Why?
|
Fatigue | 1 | 2017 | 1549 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2012 | 591 | 0.080 |
Why?
|
Observer Variation | 2 | 2014 | 2615 | 0.080 |
Why?
|
Hamartoma | 1 | 2011 | 233 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1727 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 3050 | 0.080 |
Why?
|
Deglutition Disorders | 1 | 2015 | 639 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1273 | 0.080 |
Why?
|
Headache | 1 | 2017 | 1259 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1412 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1677 | 0.080 |
Why?
|
Protein Array Analysis | 1 | 2010 | 399 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3111 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3850 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 2 | 2010 | 1066 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2016 | 1165 | 0.070 |
Why?
|
Thigh | 1 | 2009 | 238 | 0.070 |
Why?
|
Animals | 18 | 2024 | 168764 | 0.070 |
Why?
|
Bacteremia | 1 | 2014 | 989 | 0.070 |
Why?
|
Diagnostic Errors | 4 | 2018 | 1275 | 0.070 |
Why?
|
Hospitals, General | 1 | 2012 | 802 | 0.070 |
Why?
|
Prognosis | 4 | 2023 | 29922 | 0.070 |
Why?
|
Ultraviolet Rays | 2 | 2024 | 1102 | 0.070 |
Why?
|
Dendritic Cells | 1 | 2018 | 2747 | 0.070 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1774 | 0.070 |
Why?
|
Multiprotein Complexes | 1 | 2013 | 1107 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1823 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3432 | 0.070 |
Why?
|
Bleomycin | 2 | 2022 | 491 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2015 | 20659 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1630 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1882 | 0.070 |
Why?
|
Prednisone | 1 | 2011 | 1565 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 36532 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1543 | 0.070 |
Why?
|
Gadolinium DTPA | 1 | 2009 | 823 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2015 | 9601 | 0.060 |
Why?
|
Bone Diseases, Metabolic | 1 | 2010 | 407 | 0.060 |
Why?
|
Massachusetts | 3 | 2019 | 8875 | 0.060 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2887 | 0.060 |
Why?
|
Sex Factors | 1 | 2019 | 10603 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2822 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2014 | 820 | 0.060 |
Why?
|
Child, Preschool | 4 | 2018 | 42500 | 0.060 |
Why?
|
Cartilage, Articular | 1 | 2012 | 1089 | 0.060 |
Why?
|
Weight Loss | 1 | 2017 | 2710 | 0.060 |
Why?
|
Creatinine | 1 | 2011 | 1915 | 0.060 |
Why?
|
Betapapillomavirus | 1 | 2024 | 14 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1995 | 0.060 |
Why?
|
Fever | 1 | 2012 | 1603 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2014 | 5302 | 0.060 |
Why?
|
Skin Diseases, Viral | 1 | 2024 | 25 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2511 | 0.060 |
Why?
|
Microscopy, Atomic Force | 1 | 2024 | 250 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1410 | 0.050 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1292 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4025 | 0.050 |
Why?
|
United States | 3 | 2019 | 72903 | 0.050 |
Why?
|
Mice | 8 | 2024 | 81819 | 0.050 |
Why?
|
Finite Element Analysis | 1 | 2024 | 440 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 23 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1915 | 0.050 |
Why?
|
X-Ray Microtomography | 1 | 2024 | 454 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
Cannabidiol | 1 | 2024 | 123 | 0.050 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 2002 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2015 | 8529 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2011 | 2132 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3356 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2013 | 5783 | 0.050 |
Why?
|
Cannabinoids | 1 | 2024 | 174 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2023 | 1799 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2021 | 65188 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2015 | 22223 | 0.050 |
Why?
|
Macrophages | 1 | 2016 | 5772 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4850 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2867 | 0.050 |
Why?
|
Buttocks | 1 | 2021 | 110 | 0.050 |
Why?
|
Lower Extremity | 2 | 2021 | 1226 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2243 | 0.040 |
Why?
|
Microfibrils | 1 | 2020 | 16 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2021 | 26346 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3529 | 0.040 |
Why?
|
Indians, South American | 1 | 2020 | 34 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10729 | 0.040 |
Why?
|
Keratinocytes | 1 | 2024 | 863 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2010 | 3672 | 0.040 |
Why?
|
Child | 4 | 2018 | 80564 | 0.040 |
Why?
|
Erythema | 1 | 2021 | 262 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.040 |
Why?
|
Interleukin-13 | 1 | 2022 | 388 | 0.040 |
Why?
|
Heredity | 1 | 2020 | 149 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12056 | 0.040 |
Why?
|
Disease Progression | 3 | 2015 | 13632 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2022 | 484 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2024 | 751 | 0.040 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4893 | 0.040 |
Why?
|
Bone Transplantation | 1 | 2024 | 920 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2018 | 20124 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2012 | 5526 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 967 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2018 | 116 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4642 | 0.040 |
Why?
|
Anal Canal | 1 | 2021 | 376 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9071 | 0.040 |
Why?
|
Histones | 1 | 2009 | 2584 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2020 | 166 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 26318 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2015 | 15880 | 0.040 |
Why?
|
Hutchinson's Melanotic Freckle | 1 | 2018 | 26 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2009 | 2593 | 0.040 |
Why?
|
Fluorouracil | 1 | 2023 | 1648 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3251 | 0.040 |
Why?
|
Risk Factors | 6 | 2020 | 74840 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 428 | 0.040 |
Why?
|
Ion Channels | 1 | 2022 | 1045 | 0.040 |
Why?
|
Factor VIII | 1 | 2020 | 347 | 0.040 |
Why?
|
Remission Induction | 2 | 2015 | 2411 | 0.040 |
Why?
|
Pilot Projects | 3 | 2018 | 8733 | 0.030 |
Why?
|
Genome, Human | 1 | 2010 | 4448 | 0.030 |
Why?
|
Blood Proteins | 2 | 2020 | 1188 | 0.030 |
Why?
|
Peru | 1 | 2020 | 887 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5197 | 0.030 |
Why?
|
Bone Density | 1 | 2010 | 3491 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5696 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2020 | 517 | 0.030 |
Why?
|
Bacteriological Techniques | 1 | 2018 | 276 | 0.030 |
Why?
|
Granulation Tissue | 1 | 2016 | 92 | 0.030 |
Why?
|
Tryptases | 1 | 2017 | 177 | 0.030 |
Why?
|
Swine | 2 | 2017 | 5988 | 0.030 |
Why?
|
Lung | 1 | 2015 | 10033 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 18973 | 0.030 |
Why?
|
Antistreptolysin | 1 | 2015 | 6 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22332 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 18071 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 898 | 0.030 |
Why?
|
HIV Infections | 2 | 2024 | 17533 | 0.030 |
Why?
|
Gene Amplification | 2 | 2010 | 1091 | 0.030 |
Why?
|
Bandages | 1 | 2017 | 269 | 0.030 |
Why?
|
Thiosulfates | 1 | 2015 | 52 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2015 | 44 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18293 | 0.030 |
Why?
|
Swine, Miniature | 1 | 2017 | 971 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1997 | 564 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2354 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1624 | 0.030 |
Why?
|
Plasma Cells | 1 | 2018 | 591 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7421 | 0.030 |
Why?
|
Mohs Surgery | 1 | 2017 | 219 | 0.030 |
Why?
|
Arterioles | 1 | 2015 | 251 | 0.030 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2015 | 123 | 0.030 |
Why?
|
Electrolytes | 1 | 2015 | 280 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2018 | 1884 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1663 | 0.030 |
Why?
|
Photography | 1 | 2017 | 533 | 0.030 |
Why?
|
Administration, Topical | 1 | 2015 | 704 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30260 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22340 | 0.030 |
Why?
|
Interferons | 1 | 2017 | 714 | 0.030 |
Why?
|
Klebsiella Infections | 1 | 2014 | 146 | 0.030 |
Why?
|
Debridement | 1 | 2015 | 495 | 0.030 |
Why?
|
Oligodendroglia | 1 | 1997 | 542 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10563 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2006 | 3925 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21056 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 5189 | 0.030 |
Why?
|
Phototherapy | 1 | 2015 | 370 | 0.020 |
Why?
|
Klebsiella pneumoniae | 1 | 2014 | 253 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2012 | 164 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2012 | 360 | 0.020 |
Why?
|
Fibroblasts | 1 | 2023 | 4159 | 0.020 |
Why?
|
Cations | 1 | 2012 | 240 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2505 | 0.020 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2011 | 60 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 691 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15747 | 0.020 |
Why?
|
Dermatologic Agents | 1 | 2015 | 315 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36386 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2020 | 1067 | 0.020 |
Why?
|
RNA, Viral | 1 | 2019 | 2864 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 612 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 646 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2741 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14652 | 0.020 |
Why?
|
Transcription Factors | 1 | 2010 | 12131 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2010 | 125 | 0.020 |
Why?
|
Sarcoidosis | 1 | 2016 | 532 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 602 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2012 | 394 | 0.020 |
Why?
|
Epidermis | 1 | 2012 | 538 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 933 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 862 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1792 | 0.020 |
Why?
|
Rare Diseases | 1 | 2015 | 635 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2016 | 14448 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15842 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2010 | 476 | 0.020 |
Why?
|
Malnutrition | 1 | 2015 | 629 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2266 | 0.020 |
Why?
|
Shock, Septic | 1 | 2015 | 774 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 1013 | 0.020 |
Why?
|
Models, Biological | 1 | 2024 | 9443 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2012 | 664 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 969 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 679 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39193 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2012 | 995 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.020 |
Why?
|
Gene Deletion | 2 | 2010 | 2666 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3655 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2159 | 0.020 |
Why?
|
Genes, ras | 1 | 2010 | 658 | 0.020 |
Why?
|
Cattle | 1 | 2012 | 3801 | 0.020 |
Why?
|
Rabbits | 1 | 2012 | 4734 | 0.020 |
Why?
|
Biological Specimen Banks | 1 | 2012 | 786 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1742 | 0.020 |
Why?
|
Vaccination | 1 | 2018 | 3426 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2927 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7838 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1216 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1348 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7851 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8297 | 0.020 |
Why?
|
Indoles | 1 | 2013 | 1839 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1144 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.010 |
Why?
|
Risk | 1 | 2017 | 9591 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 1978 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 1997 | 4392 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3413 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8041 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1984 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3618 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41649 | 0.010 |
Why?
|
Thromboembolism | 1 | 2009 | 1003 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4108 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24282 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11206 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 2006 | 1158 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2394 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3797 | 0.010 |
Why?
|
Up-Regulation | 1 | 2010 | 4137 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12807 | 0.010 |
Why?
|
Software | 1 | 2014 | 4462 | 0.010 |
Why?
|
Osteoporosis | 1 | 2010 | 1582 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2010 | 2844 | 0.010 |
Why?
|
Internal Medicine | 1 | 2006 | 1064 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2012 | 3615 | 0.010 |
Why?
|
Cause of Death | 1 | 2009 | 3708 | 0.010 |
Why?
|
Vitamin D | 1 | 2012 | 3272 | 0.010 |
Why?
|
Pneumonia | 1 | 2009 | 2157 | 0.010 |
Why?
|
Apoptosis | 1 | 2013 | 9514 | 0.010 |
Why?
|
Ciliary Neurotrophic Factor | 1 | 1997 | 77 | 0.010 |
Why?
|
Janus Kinase 1 | 1 | 1997 | 108 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 17075 | 0.010 |
Why?
|
Acute-Phase Proteins | 1 | 1997 | 252 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1997 | 1546 | 0.010 |
Why?
|
Luciferases | 1 | 1997 | 713 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12509 | 0.010 |
Why?
|
Genomics | 1 | 2010 | 5929 | 0.010 |
Why?
|
Nerve Growth Factors | 1 | 1997 | 565 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7425 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11868 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9338 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1997 | 1524 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40065 | 0.010 |
Why?
|
Mutagenesis | 1 | 1997 | 1228 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21480 | 0.010 |
Why?
|
Obesity | 1 | 2015 | 13076 | 0.010 |
Why?
|
Transfection | 1 | 1997 | 5743 | 0.000 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1997 | 2423 | 0.000 |
Why?
|
Trans-Activators | 1 | 1997 | 2850 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1997 | 5786 | 0.000 |
Why?
|
Stem Cells | 1 | 1997 | 3540 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1997 | 7599 | 0.000 |
Why?
|
Cell Line | 1 | 1997 | 15543 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1997 | 12768 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11888 | 0.000 |
Why?
|